Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-06 Sale |
2020-08-10 4:19 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,073 | $271.2 | $562,205 | 45,326 (Direct) |
View |
| 2020-05-15 Sale |
2020-05-19 4:35 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
99 | $284.17 | $28,132 | 26,626 (Direct) |
View |
| 2020-05-06 Sale |
2020-05-08 4:19 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,074 | $272.85 | $565,882 | 47,399 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-24 Tax Withholding |
2021-02-26 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,898 | $217.57 | 63,643 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,080 | $211.75 | 66,541 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,962 | $214.16 | 68,621 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
44,935 | $0 | 71,583 (Direct) |
View |
| 2020-08-06 Exercise |
2020-08-10 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
509 | $155.57 | 45,326 (Direct) |
View |
| 2020-08-06 Exercise |
2020-08-10 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
1,564 | $187.53 | 45,326 (Direct) |
View |
| 2020-08-06 Exercise |
2020-08-10 4:19 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,073 | $0 | 45,326 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-08 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
510 | $155.57 | 47,399 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-08 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
1,564 | $187.53 | 47,399 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-08 4:19 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,074 | $0 | 47,399 (Direct) |
View |